Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 39555

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine (SFN-Cys) is a isothiocyanate derivative and an active metabolite of the class I and II histone deacetylase (HDAC) inhibitor and anticancer agent sulforaphane (Item Nos. 10496 | 14797).1 It is formed from sulforaphane via DL-sulforaphane glutathione (Item No. 34731) and sulforaphane cysteinylglycine intermediates by mercapturic acid pathway enzymes. SFN-Cys (20 µM) reduces invasion and migration by U87MG and U373 MG glioblastoma cells in wound healing and chamber assays, respectively.2 It decreases levels of α-tubulin, βIII-tubulin, stathmin 1, and X-linked inhibitor of apoptosis (XIAP) in, as well as reduces cell density of, paclitaxel-resistant A549 lung cancer cells (A549/T) when used at a concentration of 45 µM.3 SFN-Cys (30 µM) induces apoptosis and cell cycle arrest at the G2/M phase in U87MG and U373 MG cells.4
WARNING This product is not for human or veterinary use.
1. Quantitative measurement of sulforaphane, iberin and their mercapturic acid pathway metabolites in human plasma and urine using liquid chromatography-
2. Sulforaphane-
3. Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption. Cell Death Dis. 9(11), 1134 (2018).
4. Sulforaphane-